People With Low Levels Of ‘Celebrex Gene’ Are Resistant To Preventative Celebrex Treatment

A new study finds that individuals who have low expression of the “Celebrex gene,” 15-PGDH, are actually resistant to Celebrex treatment when used to prevent colon cancer. The study, published in this week’s issue of the Proceedings of the National Academy of Sciences (PNAS), is by Sanford Markowitz, M.D., Ph.D. – read the full Celebrex study article here.

No related posts.